ID: ALA3629729

Max Phase: Preclinical

Molecular Formula: C30H43N5O4S

Molecular Weight: 569.77

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N[C@H]1CCO[C@H](c2nc(C(=O)NCCc3ccccc3)cs2)C1

Standard InChI:  InChI=1S/C30H43N5O4S/c1-4-20(2)26(34-28(37)24-12-8-9-16-35(24)3)29(38)32-22-14-17-39-25(18-22)30-33-23(19-40-30)27(36)31-15-13-21-10-6-5-7-11-21/h5-7,10-11,19-20,22,24-26H,4,8-9,12-18H2,1-3H3,(H,31,36)(H,32,38)(H,34,37)/t20-,22-,24+,25-,26-/m0/s1

Standard InChI Key:  DWODQQODGUJQCS-XSOUBHFCSA-N

Associated Targets(non-human)

Tubulin 1327 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 569.77Molecular Weight (Monoisotopic): 569.3036AlogP: 3.47#Rotatable Bonds: 11
Polar Surface Area: 112.66Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.09CX Basic pKa: 7.09CX LogP: 3.05CX LogD: 2.87
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.38Np Likeness Score: -0.61

References

1. Park Y, Bae SY, Hah JM, Lee SK, Ryu JS..  (2015)  Synthesis of stereochemically diverse cyclic analogs of tubulysins.,  23  (21): [PMID:26474666] [10.1016/j.bmc.2015.10.003]

Source